Importantly, CD3+/CD4+ was significantly higher in the TCR UCI group than the UCD group (Figure 5C, p < 0.05), and CD8+/CD28− was significantly lower in the UCI group than the UCD group after treatment of ACT (Figure 5C, p < 0.05). The gene discussed is CD8A; the disease is urea cycle disorder.